Retevmo 160 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FJ5HT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,675
Award facts
- Contract value 100% obligated
- $30,675.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,675.38 to AmerisourceBergen Drug Corp for RETEVMO 160 mg tablets (60-count units) on September 25, 2025, with an ultimate completion date of October 17, 2025. This competitive, firm fixed-price contract with no set-aside designation represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The product will be performed from the contractor's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors, serves as a critical federal vendor supplying medications and medical supplies to military and veteran healthcare systems. RETEVMO (selumetinib) is a specialized oncology medication, consistent with AmerisourceBergen's portfolio of brand-name and generic pharmaceuticals delivered through the DLA Medical Supply Chain. As a prime contractor holding substantial federal medical procurement authority, AmerisourceBergen continues to demonstrate its capability to fulfill specialized pharmaceutical requirements through competitive federal contracting processes, supporting the Defense Health Agency and other government healthcare organizations.
Quick answers
Who was awarded contract SPE2DB25FJ5HT?
SPE2DB25FJ5HT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FJ5HT worth?
The government has obligated $30,675 on SPE2DB25FJ5HT.
Is contract SPE2DB25FJ5HT an order under another contract?
Yes. SPE2DB25FJ5HT is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ5HT competed?
The extent of competition for SPE2DB25FJ5HT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award